The HPV Vaccine

The Science:

Here is a collection of studies that I have gathered while researching the HPV vaccine. I will continue to update and add to this page as I learn more. I have organized these studies by health issues, and I also have a section dedicated to corruption and failures. Happy reading!

Autoimmune Disorders

Autoantibodies against Autonomic Nerve Receptors in Adolescent Japanese Girls after Immunization with Human Papillomavirus Vaccine


Autoimmunity, Autonomic Neuropathy, and the HPV Vaccination: A Vulnerable Subpopulation

On the relationship between human papilloma virus vaccine and autoimmune diseases

Is Chronic Fatigue Syndrome/Myalgic Encephalomyelitis a Relevant Diagnosis in Patients with Suspected Side Effects to Human Papilloma Virus Vaccine?

Suspected side effects to the quadrivalent human papilloma vaccine

No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil?

Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus


Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicryPancreatitis following human papillomavirus vaccination


Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl


Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis


A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events


Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase® (2017)


Fibromyalgia-Like Illness in 2 Girls After Human Papillomavirus Vaccination


Erythema multiforme following vaccination for human papillomavirus


Human papillomavirus vaccine and systemic lupus erythematosus

Human papilloma virus vaccine associated uveitis


Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction - a review of the regulatory evidence from the European Medicines Agency

Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80

Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study

Hypothesis: Human papillomavirus vaccination syndrome--small fiber neuropathy and dysautonomia could be its underlying pathogenesis


Immune thrombocytopenic purpura following human papillomavirus vaccination

Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis

Lichenoid Drug Eruption After Human Papillomavirus Vaccination


Postural tachycardia syndrome following human papillomavirus vaccination


Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld's syndrome).

Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature

An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women

No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil?

Neurological Issues

Reproductive Issues



Corruption and Failures

Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?

Too fast or not too fast: the FDA's approval of Merck's HPV vaccine Gardasil


Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial

HPV vaccines and cancer prevention, science versus activism

Who Profits From Uncritical Acceptance of Biased Estimates of Vaccine Efficacy and Safety?

Was amorphous aluminium hydroxyphosphate sulfate adequately evaluated before authorisation in Europe?


Discrepancies in the evaluation of the safety of the human papillomavirus vaccine


Challenges of independent assessment of potential harms of HPV vaccines


Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial


HPV vaccination discourses and the construction of “at-risk” girls


HPV vaccines – A review of the first decade

Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study

Industry-Sponsored Clinical ResearchA Broken System

Letter to the Editor Response to the article of Luisa Lina Villa HPV prophylactic vaccination: The first years and what to expect from now, in press

A long story made too short: surrogate variables and the communication of HPV vaccine trial results

Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands

Cost-Effectiveness Analysis of a Quadrivalent Human Papilloma Virus Vaccine in Mexico

Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up